Among the eight trials included in the present meta‐analysis, the results of six trials17, 18, 21, 22, 23, 27 suggested that incretin drugs have the effect of improving the cognition of diabetes patients, and the results of two trials20, 26 were negative. This evidence concerns the gene GCG and diabetes mellitus.